ArticleJournal of cancer education : the official journal of the American Association for Cancer Education2026
Acceptability of an Anal Cancer Screening Chatbot Among High-Risk Men Undergoing Community-Based Screening.
Article in Journal of cancer education : the official journal of the American Association for Cancer Education, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Anal cancer incidence and mortality are increasing in the United States, with highest risk among men who have sex with men (MSM) and people living with HIV. Targeted anal cancer screening is recommended for these populations. Low awareness, stigma, and limited provider engagement are barriers to implementation of anal cancer screening guidelines. Artificial intelligence (AI)-powered chatbots may offer scalable, stigma-sensitive education and follow-up support, but their acceptability for anal cancer prevention is unknown. To assess attitudes toward an AI-powered anal cancer prevention chatbot among high-risk adults undergoing onsite screening, and identify demographic, behavioral, and clinical correlates of favorable attitudes. A cross-sectional survey was conducted during a Midwestern LGBT pride festival (June 2025). Eligible participants were ≥ 35 years, male at birth, with a history of anal intercourse, and no prior anal cancer diagnosis. Attitudes toward a prevention chatbot were measured using six Likert-type items (comfort, helpfulness/accuracy, willingness to use for risk assessment and results delivery; 1–5 scale). A composite index (Cronbach’s α = 0.97) was dichotomized (> 3 = favorable). Logistic regression estimated associations between covariates and favorable attitudes. Results. The sample (N = 107) was predominantly cisgender men (95.3%), gay-identified (89.5%), and White (84.1%), with mean age 49 years. The chatbot beliefs and attitudes index mean was 3.17 (SD = 1.26; range 1–5); 48.1% reported favorable attitudes. No demographic, behavioral, or clinical variables were significant predictors. Adjusted predicted probabilities were similar by age (35–44: 53%; ≥45: 49%) and higher among HIV-positive (67%) versus HIV-negative (49%) participants. Attitudes toward an AI-powered chatbot for anal cancer prevention were largely positive. Chatbot-based education may complement community-based screening by addressing persistent informational and motivational barriers.
Indexed as
Identifiers
41826694What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.